EyePoint Plc (EYPT)
18.25
+0.36
(+2.01%)
USD |
NASDAQ |
Dec 31, 15:40
EyePoint EPS Diluted (Quarterly): -0.8513 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Agios Pharmaceuticals, Inc. | -1.779 |
| Viking Therapeutics, Inc. | -0.8083 |
| Tango Therapeutics, Inc. | 0.1431 |
| NovaBay Pharmaceuticals, Inc. | -0.22 |
| Palatin Technologies, Inc. | 4.258 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -59.73M |
| Revenue (Quarterly) | 0.966M |
| Total Expenses (Quarterly) | 60.70M |
| Enterprise Value | 1.300B |
| Gross Profit Margin (Quarterly) | 25.36% |
| Profit Margin (Quarterly) | -6.18K% |
| Earnings Yield | -16.38% |
| Normalized Earnings Yield | -16.38 |